文献速递泌尿系感染前列腺增生与排尿功能障碍

耻骨切除与尿路重建可根治前列腺癌治疗后的耻骨联合尿瘘

Pubectomy and urinary reconstruction provides definitive treatment of urosymphyseal fistula following prostate cancer treatment.
PubMed 文献 · BJU Int · 2021-02-17

该回顾性研究纳入25例前列腺癌治疗后确诊耻骨联合尿瘘(UF)并接受耻骨切除联合尿路重建的患者。所有患者均有盆腔放疗史,多数表现为行走时腹股沟区剧痛,术后疼痛显著改善且功能恢复,但32%出现90天内严重并发症。结论认为内镜尿道操作是放疗后UF的危险因素,保守治疗无效,手术可有效治疗慢性感染并改善疼痛与ECOG评分。

要点

  • 前列腺癌放疗后行内镜尿道操作是耻骨联合尿瘘的危险因素。
  • 保守治疗不能缓解症状,需行瘘减压、骨切除与尿路重建。
  • 术后96%患者疼痛缓解,ECOG评分中位数由3降至0。

核心结论

  • 耻骨切除联合尿路重建可有效治疗慢性感染、改善疼痛并恢复功能状态。
  • 保守管理无法使耻骨联合尿瘘症状缓解。

研究设计与样本

  • 回顾性研究,纳入25例前列腺癌治疗后确诊耻骨联合尿瘘并接受耻骨切除与尿路重建的患者。

主要发现

  • 25例患者均有前列腺癌盆腔放疗史。
  • 从前列腺癌治疗至确诊耻骨联合尿瘘的中位(IQR)时间为11(6,16.5)年。
  • 24/25(96%)患者表现为行走时严重的腹股沟区疼痛。
  • 20/25(80%)存在后尿道狭窄,其中60%接受过反复内镜治疗。
  • 耻骨骨标本培养显示80%存在活动性感染;术前尿液与术中骨培养不一致率为21/22(95.5%)。

临床怎么用

  • 对前列腺癌放疗后出现腹股沟疼痛及尿道狭窄者,应警惕耻骨联合尿瘘。
  • 确诊后不宜仅保守治疗,应评估行瘘减压、骨切除与尿路重建。
  • 术前尿培养与术中骨培养常不一致,需重视骨培养指导抗感染。

局限性

  • 回顾性设计,样本量仅25例。
  • 单中心经验,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the natural history, reconstructive solutions, and functional outcomes of those men undergoing pubectomy and urinary reconstruction after prostate cancer treatment. PATIENTS AND METHODS: This study retrospectively identified 25 patients with a diagnosis of urosymphyseal fistula (UF) following prostate cancer therapy who were treated with urinary reconstruction with pubectomy. This study describes the natural history, reconstructive solutions, and functional outcomes of this cohort. RESULTS: All 25 patients had a history of pelvic radiotherapy for prostate cancer. The median (interquartile range [IQR]) time from prostate cancer treatment to diagnosis of UF was 11 (6, 16.5) years. The vast majority of men (24/25; 96%) presented with debilitating groin pain during ambulation. Posterior urethral stenosis was common (20/25; 80%), with 60% having repetitive endoscopic treatments. Culture of pubic bone specimens demonstrated active infection in 80%. Discordance between preoperative urine and intraoperative bone cultures was common, 21/22 (95.5%). After surgery, major 90-day complications (Clavien-Dindo Grade III and IV) occurred in eight (32%) patients. Pain was significantly improved, with resolution of pain (24/25; 96%) and restoration of function, the median (IQR) preoperative Eastern Cooperative Oncology Group Performance Status (ECOG PS) was 3 (2, 3) vs median postoperative ECOG PS score of 0 (0, 1). CONCLUSION: Endoscopic urethral manipulation after radiation for prostate cancer is a risk factor for UF. Conservative management will not provide symptom resolution. Fistula decompression, bone resection, and urinary reconstruction effectively treats chronic infection, improves pain and ECOG PS scores.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Andrews JR, Hebert KJ, Boswell TC, et al. Pubectomy and urinary reconstruction provides definitive treatment of urosymphyseal fistula following prostate cancer treatment. BJU Int. 2021. PMID: 33403768. doi:10.1111/bju.15333

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。